Kiniksa Pharmaceuticals
KNSA
#4663
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
Kiniksa Pharmaceuticals (KNSA) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $87.77 M
According to Kiniksa Pharmaceuticals 's latest financial reports the company's total liabilities are $87.77 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Kiniksa Pharmaceuticals - Total liabilities on balance sheet (from 2017 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $87.48 M | 37.72% |
| 2022-12-31 | $63.52 M | 33% |
| 2021-12-31 | $47.76 M | 27.27% |
| 2020-12-31 | $37.52 M | 28.92% |
| 2019-12-31 | $29.11 M | -31.82% |
| 2018-12-31 | $42.69 M | -68.88% |
| 2017-12-31 | $0.13 B | 66.91% |
| 2016-12-31 | $82.19 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -68.19% | 🇺🇸 USA |